Review: taking Spironolactone and Torsemide together


Summary

Drug interactions are reported among people who take Spironolactone and Torsemide together. This review analyzes the effectiveness and drug interactions between Spironolactone and Torsemide. It is created by eHealthMe based on reports of 2,412 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Spironolactone

Spironolactone has active ingredients of spironolactone. It is often used in high blood pressure. (latest outcomes from Spironolactone 41,317 users)

Torsemide

Torsemide has active ingredients of torsemide. It is often used in high blood pressure. (latest outcomes from Torsemide 10,684 users)

On Sep, 19, 2016

2,412 people who take Spironolactone, Torsemide are studied.


Number of reports submitted per year:

Spironolactone and Torsemide drug interactions.

Drug effectiveness over time:

Spironolactone:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 20.0% - (1 of 5 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Torsemide:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 50.0% - (2 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Spironolactone:
  • female: 0.0% - (0 of 6 people)
  • male: 50.0% - (1 of 2 people)
Torsemide:
  • female: 33.0% - (2 of 6 people)
  • male: 50.0% - (1 of 2 people)

Drug effectiveness by age:

Spironolactone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 3 people)
  • 60+: 0.0% - (0 of 4 people)
Torsemide:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 3 people)
  • 60+: 50.0% - (2 of 4 people)

Most common drug interactions over time *:

< 1 month:
  • renal failure acute
  • infection
  • pruritus
  • diarrhoea
  • toxic epidermal necrolysis
  • platelet count decreased
  • anaemia
  • pyrexia
  • hypotension
  • stevens-johnson syndrome
1 - 6 months:
  • renal failure acute
  • blood sodium decreased
  • metabolic alkalosis
  • renal failure
  • dehydration
  • diarrhoea
  • general physical health deterioration
  • blood potassium decreased
  • hypotension
  • oedema peripheral
6 - 12 months:
  • hyperkalaemia
  • diarrhoea
  • hepatic encephalopathy
  • dehydration
  • dizziness
  • bradycardia
  • colitis ischaemic
  • dyspnoea
  • fall
  • fluid retention
1 - 2 years:
  • renal failure acute
  • hyperkalaemia
  • vomiting
  • carotid artery stenosis
  • dizziness
  • hypertensive crisis
  • hypotension
  • nausea
  • bradycardia
  • general physical health deterioration
2 - 5 years:
  • renal failure acute
  • hyperkalaemia
  • deep vein thrombosis
  • pulmonary oedema
  • somnolence
  • dyspnoea
  • atrial fibrillation
  • encephalopathy
  • angina pectoris
  • bradycardia
5 - 10 years:
  • anaemia
  • bradycardia
  • cardiac arrest
  • gastritis haemorrhagic
  • haematemesis
  • arrhythmia
  • blood pressure decreased
  • cardio-respiratory arrest
  • dyspnoea
  • encephalopathy
10+ years:
  • blood glucose increased
  • cardio-respiratory arrest
  • coagulopathy
  • conduction disorder
  • dehydration
  • diarrhoea
  • fall
  • gastrooesophageal reflux disease
  • haematuria
  • haemorrhagic anaemia
not specified:
  • dyspnoea
  • cardiac failure congestive
  • hypotension
  • fatigue
  • renal failure acute
  • nausea
  • atrial fibrillation
  • cardiac failure
  • renal failure
  • vomiting

Most common drug interactions by gender *:

female:
  • dyspnoea
  • cardiac failure congestive
  • renal failure acute
  • oedema peripheral
  • nausea
  • fatigue
  • vomiting
  • hypotension
  • anaemia
  • dehydration
male:
  • hypotension
  • renal failure acute
  • cardiac failure congestive
  • dyspnoea
  • fatigue
  • atrial fibrillation
  • nausea
  • cardiac failure
  • diarrhoea
  • dizziness

Most common drug interactions by age *:

0-1:
  • renal failure
  • renal failure acute
  • blood potassium increased
  • cardiac failure
  • myocardial fibrosis
  • sepsis
  • asthma
  • blood chloride decreased
  • blood pressure decreased
  • blood sodium decreased
2-9:
  • cyanosis
  • hypotension
  • pyrexia
  • renal failure acute
  • fatigue
  • renal failure
  • sepsis
10-19:
  • dizziness
  • abdominal pain
  • blood pressure decreased
  • cough
  • flushing
  • headache
  • malaise
  • atrial fibrillation
  • cardiac failure
  • cardiac failure congestive
20-29:
  • abdominal pain upper
  • bronchitis
  • cardiac failure congestive
  • cholecystitis
  • influenza like illness
  • urinary tract infection
  • atrial fibrillation
  • insomnia
  • intracardiac thrombus
  • presyncope
30-39:
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • pleural effusion
  • blood bilirubin increased
  • nausea
  • oedema lower limb
  • white blood cell count increased
  • cardiac failure
  • dyspnoea
  • right ventricular failure
40-49:
  • pain
  • diarrhoea
  • dyspnoea
  • fatigue
  • vomiting
  • cardiac failure congestive
  • atrial fibrillation
  • nausea
  • sleep apnoea syndrome
  • hypotension
50-59:
  • cardiac failure congestive
  • dyspnoea
  • renal failure acute
  • pneumonia
  • chest pain
  • pain
  • nausea
  • asthenia
  • headache
  • atrial fibrillation
60+:
  • renal failure acute
  • hypotension
  • dyspnoea
  • fatigue
  • cardiac failure congestive
  • nausea
  • cardiac failure
  • atrial fibrillation
  • dehydration
  • diarrhoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Spironolactone and Torsemide?

Can you answer these questions?

More questions for: Spironolactone, Torsemide

You may be interested in these reviews

More reviews for: Spironolactone, Torsemide

On eHealthMe, Spironolactone (spironolactone) is often used to treat high blood pressure. Torsemide (torsemide) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.